Skip to content

Outcomes of Neurosurgical Tone Management

Outcomes of Neurosurgical Tone Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07817745
Enrollment
100
Registered
2026-09-14
Start date
2024-06-26
Completion date
2031-01-01
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy (CP), Spastic/Dystonic Quadriplegia

Keywords

CP, Cerebral Palsy, Tone Management, Dystonic, Spastic, Spasticity, Intrathecal Baclofen Pump, Combined Dorsal/Ventral Rhizotomy

Brief summary

Patients with spastic/dystonic quadriplegia (GMFCS IV/V) are often severely disabled by their tone, and require surgical tone management to improve quality of life, allow for better function, improve comfort, and range of motion. This has historically been limited to Intrathecal Baclofen (ITB) pumps, which are effective for up to 85% of patients but carry significant morbidity / complications and are not appropriate for many patients. More recently, combined dorsal/ventral rhizotomy (CR) has emerged as an alternative means for tone control, a one-time surgery with no required hardware implantation. However, more information is needed regarding long-term outcomes of this procedure in addition to comparative outcomes of ITB. This information will lead to improved patient selection, counseling, and care. This is a prospectively enrolled, single-center study, involving survey administration and clinical observation of outcomes pre- and post-surgery.

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Any patients undergoing intrathecal baclofen pump insertion or combined dorsal ventral rhizotomy at Boston Children's Hospital. * Must be at least 6 years of age at time of enrollment

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Improved Spasticity ScoreFrom enrollment to 5 yearsWe will study changes in Spasticity using the Modified Ashworth Scale in participants over the course of this study.
Improved Dystonia ScoreFrom enrollment to 5 years.We will use the Barry Albright Dystonia Scale to measure changes in dystonia in participants over the course of this study.

Secondary

MeasureTime frameDescription
Overall Quality of Life ImprovementsFrom enrollment to 5 yearsWe will use the CP-Child survey to measure quality of life changes in participants over the course of this study. Specifically looking at trends in caregiver satisfaction with hygiene, and comfort.
Reduced Surgical ComplicationsFrom enrollment to 5 years.We will review outcomes for our participants to quantify surgical complications such as infection, malfunction, re-operation, spinal fluid leak, prolonged urinary retention, muscle wasting, and decubitus ulcer formation.

Countries

United States

Contacts

CONTACTAdam Porter, Research Manager, MPH
adam.porter@childrens.harvard.edu617-919-6013
PRINCIPAL_INVESTIGATORWeston Northam, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026